Skip to content
DataLookout
Menu

NCT07748195

DNA Methylation in PMR

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Eligibility criteria expanded, about 5 words
    • Study sites: 0 to 1
  2. Notable Start date: Jul 20, 2026 to Aug 31, 2026v3
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Understanding what the exact triggers for immune activation, the specific antigens involved, and the mechanisms underlying disease relapses and glucocorticoid resistance
Timeframe: 12 months

Arms and interventions

PMR diagnosed

individuals who have a PMR diagnosis

Healthy Volunteers

Healthy individuals, without a PMR diagnosis, which will allow age and sex matches with the PMR diagnosed cohort.

Sites

1 site in 1 country

  • Dartmouth Hitchcock Medical CenterLebanon, New Hampshire, United States